<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045083">
  <TermName>rofecoxib</TermName>
  <TermPronunciation>(ROH-feh-KOK-sib)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent the growth of new blood vessels that tumors need to grow. It is a type of nonsteroidal anti-inflammatory drug and a type of antiangiogenesis agent. Rofecoxib was taken off the market in the U.S. because of safety concerns. Also called Vioxx.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000704977" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rofecoxib&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000704976" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rofecoxib&quot;" language="es" id="_4"/>
  <SpanishTermName>rofecoxib</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usaba para aliviar el dolor y que estaba en estudio por su capacidad de prevenir el cáncer y de impedir la formación de vasos sanguíneos nuevos que los tumores necesitan para crecer. Es un tipo de medicamento antiinflamatorio no esteroideo y de antiangiogénico. Rofecoxib se retiró del mercado de los Estados Unidos debido a problemas de seguridad. También se llama Vioxx.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2009-04-21</DateLastModified>
</GlossaryTerm>
